A luminal stent is a tubular body formed by knitting a sole yarn of a bioresorbable polymer fiber, such as fiber of polylactic acid, polyglycol acid or a polylactic acid—polyglycol acid copolymer. When introduced into and attached to the inside of the vessel by a catheter fitted with a balloon, the tubular member may retain its shape for several weeks to several months after attachment and subsequently disappears by being absorbed into the living tissue. In this manner, the luminal stent is not left as a foreign matter semi-permanently in the living body without producing inflammation or hypertrophy in the vessel. There is also provided a method for attaching the luminal stent in the vessel.
|
1. A luminal stent, which is to be inserted into a vessel of a living body, consisting of a homogeneous tubular member produced by knitting a sole bioresorbable polymer fiber.
12. A luminal stent, which is to be inserted into a vessel of a living body, consisting of a homogeneous heat-set tubular member produced by knitting a sole bioresorbable polymer fiber.
13. A luminal stent, which is to be inserted into a vessel of a living body, consisting of a homogeneous double heat-set tubular member produced by knitting a sole bioresorbable polymer fiber.
2. The luminal stent as defined in
3. The luminal stent as defined in
4. The luminal stent as defined in
5. The luminal stent as defined in
6. The luminal stent as defined in
7. The luminal stent as defined in
8. The luminal stent as defined in
9. The luminal stent as defined in
10. The luminal stent as defined in
11. The luminal stent holding structure comprising the luminal stent as defined in
|
This application is a continuation of Application Ser. No. 08/794,396 filed Feb. 5, 1997, Experiment 1
Plural luminal stents formed by knitting a yarn of polylactic acid fibers admixed with barium sulfate were introduced and attached in the coronary of a test animal in a tubular state of 4 mm in diameter and 20 mm in length by using a catheter fitted with a balloon, and the state of attachment was observed by irradiation of X-rays. It was seen that the stents substantially maintained their shape until after about three to six months. It was seen that the stents disappeared by being absorbed into living tissue in about 6 to 12 months. During this time, no abnormalities such as inflammation or hypertrophy of the intima of the blood vessel were observed.
Plural luminal stents formed by knitting a yarn of polyglycolic acid fibers admixed with barium sulfate were introduced and attached in the femoral artery of a test animal in a tubular state of 4 mm in diameter and 20 mm din length and the state of attachment was observed by irradiation of X-rays. It was seen that the stents substantially maintained their shape until after about two to three weeks and were absorbed into the living tissue in about two to three months. The shape retention period and the period of existence in the living body attained in Experiment 2 are thought to be more safe than the corresponding periods attained in Experiment 1. Meanwhile, no inflammation or hypertrophy of the intima of the blood vessel was observed during these periods.
Patent | Priority | Assignee | Title |
10004511, | Mar 25 2011 | Covidien LP | Vascular remodeling device |
10470902, | Oct 22 2006 | IDev Technologies, Inc. | Secured strand end devices |
10478194, | Sep 23 2015 | Covidien LP | Occlusive devices |
10736758, | Mar 15 2013 | Covidien LP | Occlusive device |
10828182, | Sep 29 2011 | Covidien LP | Vascular remodeling device |
11147563, | Mar 25 2011 | Covidien LP | Vascular remodeling device |
11207448, | Nov 26 2015 | JAPAN MEDICAL DEVICE TECHNOLOGY CO., LTD.; National University Corporation Kumamoto University | Bioabsorbable stent |
11357510, | Sep 23 2015 | Covidien LP | Occlusive devices |
11389309, | Mar 15 2013 | Covidien LP | Occlusive device |
11406405, | Nov 06 2012 | Covidien LP | Multi-pivot thrombectomy device |
11654037, | Sep 29 2011 | Covidien LP | Vascular remodeling device |
11707371, | May 13 2008 | Covidien LP | Braid implant delivery systems |
11844528, | Apr 21 2008 | Covidien LP | Multiple layer filamentary devices for treatment of vascular defects |
7780641, | Jun 14 2007 | Cedars-Sinai Medical Center | Transcecal ileostomy set |
7927529, | Jan 06 2006 | Cordis Corporation | Method of forming bioabsorbable drug delivery devices |
7972373, | Dec 19 2007 | CARDINAL HEALTH SWITZERLAND 515 GMBH | Balloon expandable bioabsorbable stent with a single stress concentration region interconnecting adjacent struts |
8088060, | Mar 15 2000 | ORBUSNEICH MEDICAL PTE LTD | Progenitor endothelial cell capturing with a drug eluting implantable medical device |
8414635, | Feb 01 1999 | IDev Technologies, Inc. | Plain woven stents |
8419788, | Oct 22 2006 | IDev Technologies, Inc. | Secured strand end devices |
8460367, | Mar 15 2000 | ORBUSNEICH MEDICAL PTE LTD | Progenitor endothelial cell capturing with a drug eluting implantable medical device |
8739382, | Oct 22 2006 | IDev Technologies, Inc. | Secured strand end devices |
8747597, | Apr 21 2008 | NFOCUS LLC; Covidien LP | Methods for making braid-ball occlusion devices |
8784465, | Oct 11 2002 | Boston Scientific Scimed, Inc.; University of Connecticut | Implantable medical devices |
8858520, | Apr 22 2008 | CONVATEC TECHNOLOGIES INC | Temporary ostomy appliance |
8876880, | Feb 01 1999 | Board of Regents, The University of Texas System | Plain woven stents |
8876881, | Oct 22 2006 | IDEV TECHNOLOGIES, INC | Devices for stent advancement |
8926681, | Jan 28 2010 | Covidien LP | Vascular remodeling device |
8966733, | Oct 22 2006 | IDev Technologies, Inc. | Secured strand end devices |
8974516, | Feb 01 1999 | Board of Regents, The University of Texas System | Plain woven stents |
9023095, | May 27 2010 | IDEV TECHNOLOGIES, INC | Stent delivery system with pusher assembly |
9039726, | Apr 21 2008 | NFOCUS LLC; Covidien LP | Filamentary devices for treatment of vascular defects |
9060886, | Sep 29 2011 | Covidien LP | Vascular remodeling device |
9089332, | Mar 25 2011 | Covidien LP | Vascular remodeling device |
9095342, | Nov 09 2009 | NFOCUS LLC; Covidien LP | Braid ball embolic device features |
9115245, | Jul 18 2002 | Boston Scientific Scimed, Inc. | Implantable medical devices |
9149374, | Oct 22 2006 | IDEV TECHNOLOGIES, INC | Methods for manufacturing secured strand end devices |
9179918, | Jul 22 2008 | Covidien LP | Vascular remodeling device |
9295571, | Jan 17 2013 | Covidien LP | Methods and apparatus for luminal stenting |
9314248, | Nov 06 2012 | Covidien LP | Multi-pivot thrombectomy device |
9320837, | May 12 2006 | CARDINAL HEALTH SWITZERLAND 515 GMBH | Balloon expandable bioabsorbable drug eluting flexible stent |
9393022, | Feb 11 2011 | Covidien LP | Two-stage deployment aneurysm embolization devices |
9408729, | Oct 22 2006 | IDev Technologies, Inc. | Secured strand end devices |
9408730, | Oct 22 2006 | IDev Technologies, Inc. | Secured strand end devices |
9463105, | Mar 14 2013 | Covidien LP | Methods and apparatus for luminal stenting |
9468442, | Jan 28 2010 | Covidien LP | Vascular remodeling device |
9522217, | Mar 15 2000 | ORBUSNEICH MEDICAL PTE LTD | Medical device with coating for capturing genetically-altered cells and methods for using same |
9585669, | Apr 21 2008 | NFOCUS LLC; Covidien LP | Multiple layer filamentary devices for treatment of vascular defects |
9585776, | Oct 22 2006 | IDev Technologies, Inc. | Secured strand end devices |
9629736, | Oct 22 2006 | IDev Technologies, Inc. | Secured strand end devices |
9895242, | Oct 22 2006 | IDEV TECHNOLOGIES, INC | Secured strand end devices |
9901472, | Jan 17 2013 | Covidien LP | Methods and apparatus for luminal stenting |
9924959, | Nov 06 2012 | Covidien LP | Multi-pivot thrombectomy device |
9925074, | Feb 01 1999 | Plain woven stents |
Patent | Priority | Assignee | Title |
4950227, | Nov 07 1988 | Boston Scientific Scimed, Inc | Stent delivery system |
5085629, | Oct 06 1988 | Cabot Technology Corporation | Biodegradable stent |
5147399, | Feb 01 1988 | SYNOVIS LIFE TECHNOLOGIES, INC | Method of treating nerve defects through use of a bioabsorbable surgical device |
5195984, | Oct 04 1988 | CARDINAL HEALTH SWITZERLAND 515 GMBH | Expandable intraluminal graft |
5274074, | Dec 17 1987 | UNITED STATES SURGICAL CORP | Medical devices fabricated from homopolymers and copolymers having recurring carbonate units |
Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
Nov 05 2002 | Kabushikikaisha Igaki Iryo Sekkei | (assignment on the face of the patent) | / |
Date | Maintenance Fee Events |
Dec 12 2007 | M2552: Payment of Maintenance Fee, 8th Yr, Small Entity. |
Oct 20 2011 | M2553: Payment of Maintenance Fee, 12th Yr, Small Entity. |
Date | Maintenance Schedule |
Mar 15 2008 | 4 years fee payment window open |
Sep 15 2008 | 6 months grace period start (w surcharge) |
Mar 15 2009 | patent expiry (for year 4) |
Mar 15 2011 | 2 years to revive unintentionally abandoned end. (for year 4) |
Mar 15 2012 | 8 years fee payment window open |
Sep 15 2012 | 6 months grace period start (w surcharge) |
Mar 15 2013 | patent expiry (for year 8) |
Mar 15 2015 | 2 years to revive unintentionally abandoned end. (for year 8) |
Mar 15 2016 | 12 years fee payment window open |
Sep 15 2016 | 6 months grace period start (w surcharge) |
Mar 15 2017 | patent expiry (for year 12) |
Mar 15 2019 | 2 years to revive unintentionally abandoned end. (for year 12) |